.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Chubb
Harvard Business School
Express Scripts
Novartis
Healthtrust
Deloitte
McKesson
AstraZeneca
Medtronic

Generated: September 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Method of treating female hypoactive sexual desire disorder with flibanserin
Abstract: The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
Inventor(s): Borsini; Franco (Bad Waldsee, DE), Evans; Kenneth Robert (Toronto, CA)
Assignee: Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:10/272,603
Patent Claims: 1. A method of treating a female hypoactive sexual desire disorder in a patient, comprising administering to said female patient in need thereof a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat said female hypoactive sexual desire disorder.

2. The method according to claim 1, wherein flibanserin is administered in form of a pharmaceutically acceptable acid addition salt thereof; and wherein said salt is formed by the addition of an acid selected from the group consisting of succinic acid, hydrobromic acid, acetic acid, fumaric acid, maleic acid, methanesuiphonic acid, lactic acid, phosphonic acid, hydrochloric acid, sulphuric acid, tartaric acid, citric acid and mixtures thereof.

3. The method according to claim 1, wherein flibanserin, or a pharmaceutically acceptable acid addition salt thereof, is administered in a dose range of from 0.1 to 400 mg per day.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Novartis
AstraZeneca
Chinese Patent Office
Healthtrust
Citi
Medtronic
McKesson
Baxter
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot